1. Primary Report & Key Facts: Sls Stock
Tracked under Business in Canada (with 200+ searches recorded on Google Trends), primary reporting from Yahoo! Finance Canada states: "Lilly to acquire Calytrix Bio in deal worth up to $1.5 billion". Full source links and direct publisher coverage are provided below.
2. Source Verification & Editorial Disclosure
Additional press coverage notes: Eli Lilly Agrees to Buy Calytrix Bio for Up to $1.5 Billion (Bloomberg.com). Further reporting includes: Eli Lilly to Buy Calytrix Bio for Up to $1.5 Billion (WSJ). Editorial Disclosure: This briefing is automatically assembled from the cited primary sources and reviewed under STBAC Radar's editorial policy (info@stbac.com).